Showing results (691-700 of 1,838) with videos related to
Sort By:
Pageof 184
ESMO Open|November 16, 2016
Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative reviewPeter Schellongowski, Wolfgang R Sperr, Philipp Wohlfarth, et al.ESMO Open|November 16, 2016
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapyChiara Ambrogio, Ernest Nadal, Alberto Villanueva, et al.ESMO Open|February 23, 2019
Implementing TMB measurement in clinical practice: considerations on assay requirementsReinhard Büttner, John W Longshore, Fernando López-Ríos, et al.ESMO Open|August 20, 2019
Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studiesIwao Osaka, Hiroto Ishiki, Takaaki Yokota, et al.ESMO Open|August 20, 2019
Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumabChristopher Nevala-Plagemann, Justin Moser, Glynn Weldon Gilcrease, et al.ESMO Open|November 15, 2018
Risk factors for the development of brain metastases in patients with HER2-positive breast cancerChristian Maurer, Lorraine Tulpin, Michel Moreau, et al.ESMO Open|November 15, 2018
Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinomaSaori Mishima, Akihito Kawazoe, Hiroshi Matsumoto, et al.ESMO Open|July 30, 2019
How I treat gastric adenocarcinomaMaria Alsina, Josep Maria Miquel, Marc Diez, et al.ESMO Open|March 4, 2017
Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky diseaseMarkus Kieler, Werner Scheithauer, Christoph C Zielinski, et al.ESMO Open|March 4, 2017
Emerging challenges of advanced squamous cell lung cancerYi-Chen Zhang, Qing Zhou, Yi-Long WuPageof 184